StemCell Institute (7096) · PolicyAdvanced
Review of the Rationale for Strategic Shareholdings and the Exercise of Voting Rights
First written in FY2022. 2 of 3 entries say "Advanced", first in FY2023. Latest entry: FY2025.
3entries
4years
0from disclosures
How it moved
Same theme, other companies
Verification of the Rationale for Holding Cross-ShareholdingsA theme 1356 companies write about · 1 as a headwind · 715 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1360 threads.Full recordFilings, disclosures and news, newest first
- FY2025AdvancedAnnual report
「All of the shares were sold during the fiscal year.」
The Company sold all 50,000 shares of Cuorips Inc. held as cross-shareholdings. It continues to hold shares of baby calendar Inc. to strengthen business partnerships, including through the reciprocal use of advertising media. - FY2023AdvancedAnnual report
「The shares are held to strengthen business partnerships, including through the reciprocal use of advertising media.」
As cross-shareholdings, the Company acquired and holds 18,800 shares of baby calendar Inc., with a carrying amount on the balance sheet of ¥46.041 million, to strengthen business partnerships through the reciprocal use of advertising media and other means. - FY2022First statedAnnual report
「The Company's investment shares held for purposes other than pure investment are held from the perspective of enhancing corporate value over the medium to long term, with the objectives of building long-term, stable relationships with business partners and promoting sales. For each holding, the Company reviews and verifies its holding policy annually, taking into account profitability and other factors.」
For cross-shareholdings, the Company disclosed for the first time as a standalone disclosure its policy of holding shares for business relationships, sales promotion and medium- to long-term corporate value enhancement, with annual, stock-by-stock verification and detailed scrutiny of voting.